Elise is a product manager for bioinformatics, focusing on internal and external applications of biological data to investment processes and the portfolio.
Elise joined Foresite Capital from the Institute of Cancer Research (ICR), where she was a senior computational biologist focused on discovery, characterization and utilization of cancer predisposition genes. She also served as informatics coordinator for the Transforming Genetic Medicine Initiative (TGMI), directing design and informatics strategy for large-scale research projects in medical genetics. Elise was previously a senior bioinformatician for TGLclinical, responsible for design, implementation, validation and maintenance of clinical cancer predisposition gene testing pipelines. She holds a Ph.D. in cancer genetics from Institute of Cancer Research, a M.S. in biostatistics from UC Berkeley, and a B.S. in statistics and mathematics from University of Illinois, Urbana-Champaign.